Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis : a randomized prospective study

スポンサーリンク

概要

• 論文の詳細を見る
• 2009-05-30

著者

• SHIRAKI Masataka

  Research Institute and Practice for Involutional Diseases

• Itabashi Akira

  Saitama Center For Bone Research

• Shiraki Masataka

  Research Institute And Practice For Involutional Disease

関連論文

• Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
• Association of a Sequence Variation in the Gene Encoding Adiponectin Receptor 1 (ADIPOR1) with Body Mass Index in the Japanese Population
• Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
• Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women
• Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
• Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
• Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
• Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
• Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
• A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
• The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
• Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
• The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
• A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
• Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
• Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women
• Diagnostic criteria for primary osteoporosis: year 2000 revision
• Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
• Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
• Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
• Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
• Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure
• Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
• Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
• Association of Bone Metabolism Regulatory Factor Gene Polymorphisms With Susceptibility to Ossification of the Posterior Longitudinal Ligament of the Spine and Its Severity
• Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy
• Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
• Validation of the Japanese Osteoporosis Quality of Life Questionnaire
• Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
• Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
• Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
• Effects of phosphorus-containing calcium preparation (bone meal powder) and calcium carbonate on serum calcium and phosphorus in young and old healthy volunteers: a double-blinded crossover study
• Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis : a randomized prospective study
• A polymorphic variant at the Werner helicase(WRN)gene is associated with bone density, but not spondylosis, in postmenopausal women
• The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
• High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
• Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
• Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
• Effect of 1α-Hydroxyvitamin D_3 on Loss of Bone Mineral Density Immediately after Artificial Menopause
• ASSOCIATION OF ESTROGEN RECEPTOR DINUCLEOTIDE REPEAT POLYMORPHISM WITH OSTEOPOROSIS
• Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D_3 load in Japanese subjects
• Design of a pragmatic approach to evaluate the effectiveness of concurrent treatment for the prevention of osteoporotic fractures
• Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis
• Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
• Effect of disuse on bone mineral content, lean mass, and fat mass in osteoarthritic patients
• Bone and Calcium Metabolism in Werner's Syndrome
• Breast arterial calcification and hypertension associated with vertebral fracture
• Three years of treatment with minodronate in patients with postmenopausal osteoporosis
• Diagnostic criteria for primary osteoporosis : year 2012 revision
• Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis
• Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol

もっと見る 閉じる

スポンサーリンク